Priming mobilized peripheral blood mononuclear cells with the “activated platelet supernatant” enhances the efficacy of cell therapy for myocardial infarction of rats
- 6 July 2016
- journal article
- research article
- Published by Wiley in Cardiovascular Therapeutics
- Vol. 34 (4), 245-253
- https://doi.org/10.1111/1755-5922.12194
Abstract
Various methods are used to augment the efficacy of cell therapy in myocardial infarction (MI). In this study, we used the 'Activated Platelet Supernatant (APS)' to prime autologous 'Granulocyte colony-stimulating factor mobilized peripheral blood mononuclear cells ((mob) PBMCs)', and investigated the efficacy of cell-based therapy in MI.Rat (mob) PBMCs were isolated after daily subcutaneous injections of G-CSF at 100 μg/kg for 3 days. APS was isolated separately after activating rat platelets with thrombin 0.5 U/ml for two hours. Priming was done with APS for 6 hours. To check the paracrine effect of primed (mob) PBMCs, we used the 36 hour culture supernatant of the primed cells. A rat MI model was used for an in vivo model.Cytokines such as IL-1β, IL-10 and TGFβ were 3.7±0.9-fold, 3.4±1.2-fold, and 1.2±0.1-fold higher in APS, respectively, compared to naïve platelet supernatant. By APS-priming, (mob) PBMCs showed M2 polarization and upregulation of angiogenic molecules (i.e. TEK, IL-10, CXCL1 and CX3CR1). APS-primed (mob) PBMCs had a 2.3-fold increased adhesion ability, induced by upregulated integrins. Rat endothelial cells cultured in the 36-hour culture supernatant of APS-primed (mob) PBMCs, showed a 1.6-fold augmented proliferation and capillary network formation. In vivo transplantation of APS-primed (mob) PBMCs into rat MI models showed a significant trend of reduction in fibrosis area (p=0.001) and wall thinning (p=0.030), which lead to improvement in cardiac function measured by echocardiography.Our data reveals that APS-priming can enhance the wound healing potential of (mob) PBMCs. APS-priming may be a promising method for cell-based therapy of MI. This article is protected by copyright. All rights reserved.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2015M3A9B4051198)
- Ministry of Science, ICT and Future Planning
- Innovative Research Institute for Cell Therapy (A062260)
This publication has 34 references indexed in Scilit:
- Activated platelet supernatant can augment the angiogenic potential of human peripheral blood stem cells mobilized from bone marrow by G-CSFJournal of Molecular and Cellular Cardiology, 2014
- Erythropoietin priming improves the vasculogenic potential of G-CSF mobilized human peripheral blood mononuclear cellsCardiovascular Research, 2014
- Protective and pathogenic functions of macrophage subsetsNature Reviews Immunology, 2011
- Obstacles and opportunities for understanding macrophage polarizationJournal of Leukocyte Biology, 2011
- Differential Roles of Macrophages in Diverse Phases of Skin RepairThe Journal of Immunology, 2010
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- Wound repair and regenerationNature, 2008
- The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functionsThe Journal of Experimental Medicine, 2007
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005
- Alternative activation of macrophagesNature Reviews Immunology, 2003